Results 191 to 200 of about 5,420 (200)

Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report

British Journal of Clinical Pharmacology, 2017
Catia Marzolini, Laurent Decosterd, Thierry Buclin   +2 more
exaly  

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-1 Infection Treatment

Annals of Pharmacotherapy, 2012
, Olga M Klibanov, Linda M Spooner
exaly  

Effects of a protein‐rich drink or a standard meal on the pharmacokinetics of elvitegravir, cobicistat, emtricitabine and tenofovir in healthy Japanese male subjects: A randomized, three‐way crossover study

Journal of Clinical Pharmacology, 2014
exaly  

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Reactions Weekly, 2017
openaire   +1 more source

Elvitegravir (Vitekta) for HIV.

The Medical letter on drugs and therapeutics, 2016
openaire   +1 more source

Elvitegravir: a once-daily, boosted, HIV-1 integrase inhibitor

Expert Review of Anti-Infective Therapy, 2012
exaly  

Comprehensive Review on Different Analytical Techniques for HIV 1- Integrase Inhibitors: Raltegravir, Dolutegravir, Elvitegravir and Bictegravir

Critical Reviews in Analytical Chemistry
Priti Jain, Anusha Thota, Rajeev Singh Raghuvanshi   +2 more
exaly  

A NEW PROCESS FOR THE PREPARATION OF ELVITEGRAVIR

2015
RADL STANISLAV, STACH JAN
openaire   +1 more source

Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide

Reactions Weekly, 2016
openaire   +1 more source

VITEKTA (Elvitegravir)

2017
exaly